| Announce Date | 11/10/2025 |
| EPS Normalized Actual | $-0.25 (Beat by $0.08) |
| EPS GAAP Actual | $-0.25 (Beat by $0.08) |
| Revenue Actual | $0.111032B |
| Revenue Surprise | Beat by $111.032M |
| Announce Date | 01/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.29 |
| EPS GAAP Estimate | $0.29 |
| Revenue Estimate | $0.1437B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Jul 2027 | -0.12 | -47.5 | -0.12315 | -0.11648 | 1 |
| Jul 2026 | 0.44 | 12.95 | 0.40418 | 0.47666 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | -0.67 | -0.96 | 0.111032B | -4.29% | -31.17M |
| FQ3 2025 (Jul 2025) | -0.39 | -0.52333 | 0.130367B | 3.2% | -17.93M |
| FQ2 2025 (Apr 2025) | -0.49 | -0.31018 | 0.126787B | -1.02% | -11.12M |
| FQ1 2025 (Jan 2025) | -0.76 | -0.76 | 0.126574B | -6.04% | 126.57M |
| FQ4 2024 (Oct 2024) | -5.29315 | -5.29315 | 0.1158B | -31.18% | 115.8M |
| FQ3 2024 (Jul 2024) | -2.68 | -2.68 | 0.126191B | -17.93% | 126.19M |
| FQ2 2024 (Apr 2024) | 0.0969 | 0.0969 | 0.128076B | 100% | 128.08M |
| FQ1 2024 (Jan 2024) | -0.37 | -0.37 | 0.134225B | 100% | 134.23M |
FQ4 Announce Date
01/30/2026 (Pre-Market)
Consensus EPS Estimates
0.29
Consensus Revenue Estimates
0.1437B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2027 (Jul 2027) | -0.33 | -- | -0.33 | -0.33 | 1 |
| FQ2 2027 (Apr 2027) | -0.5 | -- | -0.5 | -0.5 | 1 |
| FQ1 2027 (Jan 2027) | -0.52 | -- | -0.52 | -0.52 | 1 |
| FQ4 2026 (Oct 2026) | -0.61 | -9.84 | -0.61 | -0.61 | 1 |
| FQ3 2026 (Jul 2026) | 0.21 | 285.71 | 0.20554 | 0.21918 | 1 |
| FQ2 2026 (Apr 2026) | -0.55 | 10.91 | -0.55 | -0.55 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2027 (Jul 2027) | 0.12B | -- | 0.12B | 0.12B | 1 |
| FQ2 2027 (Apr 2027) | 0.12B | -- | 0.12B | 0.12B | 1 |
| FQ1 2027 (Jan 2027) | 0.12B | -- | 0.12B | 0.12B | 1 |
| FQ4 2026 (Oct 2026) | 0.11B | 1.74 | 0.11B | 0.11B | 1 |
| FQ3 2026 (Jul 2026) | 0.17B | 21.78 | 0.16B | 0.17B | 2 |
| FQ2 2026 (Apr 2026) | 0.12B | -9.12 | 0.12B | 0.12B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
7
EPS # of in-lines
0
Revenue # of Beats
5
Revenue # of Misses
3
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | 0.29 | -0.67 | -0.96 | 143.28% |
| FQ3 2025 (Jul 2025) | 0.13333 | -0.39 | -0.52333 | 134.19% |
| FQ2 2025 (Apr 2025) | -0.17982 | -0.49 | -0.31018 | 63.3% |
| FQ1 2025 (Jan 2025) | -0.76 | -0.76 | 100% | |
| FQ4 2024 (Oct 2024) | -5.29315 | -5.29315 | 100% | |
| FQ3 2024 (Jul 2024) | -2.68 | -2.68 | 100% | |
| FQ2 2024 (Apr 2024) | 0.0969 | 0.0969 | 100% | |
| FQ1 2024 (Jan 2024) | -0.37 | -0.37 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | $0.14B | $0.11B | $-31.17M | -28.07% |
| FQ3 2025 (Jul 2025) | $0.15B | $0.13B | $-17.93M | -13.76% |
| FQ2 2025 (Apr 2025) | $0.14B | $0.13B | $-11.12M | -8.77% |
| FQ1 2025 (Jan 2025) | $0B | $0.13B | $126.57M | 100% |
| FQ4 2024 (Oct 2024) | $0B | $0.12B | $115.8M | 100% |
| FQ3 2024 (Jul 2024) | $0B | $0.13B | $126.19M | 100% |
| FQ2 2024 (Apr 2024) | $0B | $0.13B | $128.08M | 100% |
| FQ1 2024 (Jan 2024) | $0B | $0.13B | $134.23M | 100% |